Physician profile
Lance Sieger
NPI 1134130248
$5,424.18
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,836 · 2020: $51.03 · 2022: $236 · 2023: $177 · 2024: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $4,438.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $326.77 | 2019-2023 | |
| Guerbet LLC | $125.00 | 2024 | |
| Alexion Pharmaceuticals, INC. | $121.90 | 2019 | |
| Novo Nordisk INC | $114.70 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $85.76 | 2019-2020 | |
| Genzyme Corporation | $61.88 | 2023 | |
| Scilex Pharmaceuticals INC. | $42.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.67 | 2019 | |
| Eisai INC. | $23.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.93 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.45 | 2020 | |
| Stemline Therapeutics INC. | $16.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Sieger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.